Design, synthesis, molecular modeling, and bioactivity evaluation of 1,10-phenanthroline and prodigiosin (Ps) derivatives and their Copper(I) complexes against mTOR and HDAC enzymes as highly potent and effective new anticancer therapeutic drugs is a research paper published in Frontiers in Pharmacology (2022). On theSindex it has a DataRank of 0.208. It has been cited 3 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.208
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: 5R01GM112490-10
Sensitive and Quantitative MS-bases Glycomic Mapping Platform
National Institutes of Health
Grant: 5R01GM130091-07
Quantitative Characterization of Glycopeptide Isomers
National Science Foundation
Grant: 1048553
Acquisition of a 400 MHz NMR Spectrometer for Research and Education in Synthetic Chemistry
National Science Foundation
Grant: 0847736
CAREER: Preparation of Materials Composed of Mechanically Interlocked Nanoscale Species
FWCI
0.40
Citation Percentile
0.6%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals